News Update: Trump 'will tie US drug prices to other countries' President Donald Trump said he will sign an order today to cut prescription drug prices in the US to the level paid by other comparable countries.
News Spectre of 'favoured nation' pricing manifests again in US President Trump is rumoured to be resurrecting a policy that would see drug prices offered to federal programmes tied to those offered overseas.
Market Access Unpacking Trump’s executive order on drug pricing, with Alic... Jonah Comstock welcomed back Alice Valder Curran to the podcast to pick apart Trump's Executive Order order piece by piece.
Market Access Buyer’s remorse: The UK’s VPAG With the ABPI wanting to change the scheme just over a year into its five-year term, it seems that they have buyer’s remorse.
News Trump pledges drug price cuts – and action on 'pill penalty' A Trump executive order aimed at lowering drug prices includes a plan to do away with what industry claims is a flaw in the Inflation Reduction Act.
Sales & Marketing Executing established pharma brand strategy: Key considerati... As blockbuster drug patents edge closer to expiry, pharma companies must rethink how they invest in, support, and scale established brands
News BMS's Breyanzi is first CAR-T for marginal zone lymphoma Bristol Myers Squibb has taken CAR-T therapy into new territory, after getting FDA approval for Breyanzi in marginal zone lymphoma.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.